London-based laboratory services company hVIVO has launched its COVID Clear antibody test and made it available on demand for larger employer groups in the U.K.
The test is run on the Mosaiq COVID-19 antibody microarray testing platform, which hVIVO licensed from diagnostics company Quotient. It requires a full blood draw taken by a nurse or general practitioner (GP), which the vendor says is much more accurate than finger stick tests and provides 100% accuracy.
hVIVO is also seeking channel partners to make the test available through GP networks, nursing services, health clinics, and private hospitals. The firm said that it has the capability to process 3,000 samples per day, 21,000 per week, and one million per year at its London virology lab. Results will be provided within 48 hours.